A legacy of excellence. A future of possibilities.

As a leader for nearly 20 years, Visualase™ laser ablation continues to drive the future of laser interstitial thermal therapy (LITT). The Visualase™ V2 platform builds on this leadership with updated automation, advanced laser safety capabilities, and greater system flexibility designed to support evolving workflow needs and operational efficiency.

The Visualase™ V2 MRI-guided laser ablation system offers:

Precision by design

When every millimeter matters, you need confidence knowing that your visualization reflects what’s happening within the tissue.

Visualase™ laser ablation is the only cranial laser ablation system with true sub-millimetric voxel size.

Every voxel represents real data — not interpolated estimates — giving you more reliable information for confident decision-making.

  • Confidence in the ablation zone: More raw data points for unparalleled visualization and control, so that you can ablate only the tissue that matters, preserving healthy brain structures.
  • Reliable damage estimates: Validated histology-based thermal damage models for accurate calculation of necrosis and transitional tissue.
  • Expanded visualization options: Zoom, pan, and TDE opacity features for improved visualization of background images and thermal damage estimate.†

Control by design

Real-time safety checks for peace of mind and a streamlined procedure.

  • Fully automated MRI drift correction: Improved thermometry accuracy for entirety of the procedure.‡
  • Streamlined workflow: Intuitive, linear task flow improves overall software usability and consistency throughout the surgical workflow.
  • Smart automation: Bidirectional hardware and software controls reduce manual tasks and simplify troubleshooting.

Versatility by design

Investing in your patients today and tomorrow.

Visualase™ V2 workstation is an upgradeable, mobile laser ablation platform designed to keep care teams at the forefront of technology, with flexibility across multiple MRI scanners and FDA clearance for patients ages 2 and older.

FDA cleared with pediatric indication

The Visualase™ V2 system is FDA cleared to support a broader range of patients,† including children ages 2 years and older.

Partnership beyond products

For nearly 20 years, the Visualase™ portfolio has served patients with brain tumor and focal epilepsy in more procedures and across more countries than any other system.

Our mission is not just about the numbers – it’s about empowering healthcare professionals to make a true difference in the lives of patients and their families around the world.

Ready to unlock the future of LITT?

Connect with us

† Compared to Visualase™ V1 MRI-guided laser ablation system.

‡ As compared to no drift correction.

Rx only. Refer to product instruction manual/package insert for instructions, warnings, precautions, and contraindications.